| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2017↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $10.8B | $10.5B | $7.4B | $7.1B | $9.0B | $7.0B | $5.4B | $12.4B |
| Cost of Revenue | $0.2B | $0.2B | $0.0B | $0.4B | $0.5B | $0.3B | $0.3B | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | — | — | — | — | — | — | — | — |
| Net Income | $0.7B | $0.7B | $0.3B | $0.8B | $1.7B | $0.3B | $0.2B | $-0.3B |
| EPS (Basic) | $2.93 | $3.08 | $1.12 | $3.13 | $6.29 | $1.12 | $0.63 | $-0.74 |
| EPS (Diluted) | $2.83 | $2.99 | $1.10 | $3.06 | $6.13 | $1.11 | $0.62 | $-0.74 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2017↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $76.0B | $64.4B | $57.9B | $51.1B | $60.4B | $53.1B | $49.5B | $47.2B |
| Current Assets | — | — | — | — | — | — | — | — |
| Cash & Equivalents | $14.0B | $12.2B | $8.5B | $9.7B | $10.8B | $9.1B | $7.7B | $5.3B |
| Total Liabilities | $65.4B | $54.1B | $48.1B | $40.6B | $49.7B | $43.5B | $39.7B | $36.5B |
| Current Liabilities | — | — | — | — | — | — | — | — |
| Stockholders' Equity | $10.6B | $10.2B | $9.7B | $10.2B | $10.6B | $9.4B | $9.6B | $10.1B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2017↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | — | — | $-1.9B | $1.8B | $1.6B | $2.1B | $-0.8B | $1.1B |
| Investing Cash Flow | $-0.3B | $0.2B | $-0.0B | $-0.1B | $-0.4B | $-0.2B | $1.7B | $-0.0B |
| Capital Expenditures | $0.2B | $0.3B | $0.0B | $0.2B | — | — | — | — |
| Financing Cash Flow | — | — | $1.1B | $-2.8B | $1.0B | $-0.7B | $1.6B | $0.4B |